MYALEPT
Live / Registered — Registered and renewed (as of 26 May 2025)
What this means for you
Registered since 19 Aug 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 Aug 2024).
Record
- Serial number
- 85484675
- Registration number
- 4589120
- Mark type
- Stylized text
- Filed
- 01 Dec 2011
- Published for opposition
- 15 May 2012
- Registered
- 19 Aug 2014
- Next maintenance due
- 19 Aug 2024
- Attorney of record
- Todd Armstrong, Ph.D.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of lipoatrophy, lipodystrophy, and leptin deficiency
Owner
- AMRYT PHARMACEUTICALS INC., DUBLIN, DE, US
- AEGERION PHARMACEUTICALS, INC., CAMBRIDGE, MA, US
- AMYLIN PHARMACEUTICALS, LLC, SAN DIEGO, CA, US
- AMYLIN PHARMACEUTICALS, LLC, SAN DIEGO, CA, US
- Amylin Pharmaceuticals, Inc., San Diego, CA, US
- Amylin Pharmaceuticals, Inc., San Diego, CA, US
Prosecution history
- 26 May 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 26 May 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 26 May 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 26 May 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Dec 2024 — TEAS SECTION 8 & 9 RECEIVED
- 19 Aug 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 23 Jun 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 01 Oct 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 01 Oct 2020 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Oct 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Aug 2020 — TEAS SECTION 8 & 15 RECEIVED
- 29 Oct 2019 — NEW CERTIFICATE UNDER SECTION 7 - PROCESSED
- 28 Oct 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 25 Sept 2019 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 23 Sept 2019 — TEAS SECTION 7 REQUEST RECEIVED